94 related articles for article (PubMed ID: 6354063)
1. Blood group antigens in urothelium in transitional cell carcinoma.
Giraldo AA; Ruby SG; Humes JJ
Ann Clin Lab Sci; 1983; 13(4):307-14. PubMed ID: 6354063
[TBL] [Abstract][Full Text] [Related]
2. [The study of the ABH isoantigen of bladder tumors].
Fukatsu H; Nonomura H; Miyagawa Y; Waki M; Hatano Y; Hiraiwa S; Muramatsu T; Takamura T; Yamada Y; Nishikawa E
Hinyokika Kiyo; 1987 Jun; 33(6):857-63. PubMed ID: 3314420
[TBL] [Abstract][Full Text] [Related]
3. [Immunohistochemical demonstration of carcinoembryonic antigen (CEA) and ABO (H) blood group antigens on tissue sections of urinary bladder tumors].
Fujioka T; Tanji S; Koike H; Kubo T; Ohhori T
Hinyokika Kiyo; 1985 Oct; 31(10):1709-16. PubMed ID: 3911765
[TBL] [Abstract][Full Text] [Related]
4. [Correlations between grading and presence of blood group isoantigens in papillary urothelial-cell carcinoma of the bladder with low grade malignancy].
Mattarozzi A; Zanella L; Bacchini P; Bertoni F; Ferramosca B
Pathologica; 1985; 77(1050):395-400. PubMed ID: 3834371
[No Abstract] [Full Text] [Related]
5. [Correlation of the expression of A, B isoantigens with its precursor H antigen in transitional cell carcinoma and the clinical signification of the expression].
Yang SC
Zhonghua Wai Ke Za Zhi; 1990 Oct; 28(10):631-3, 639. PubMed ID: 2086062
[TBL] [Abstract][Full Text] [Related]
6. Blood group antigens in transitional cell tumours of the urinary bladder. An immunohistochemical study.
Juhl BR
Dan Med Bull; 1994 Feb; 41(1):1-11. PubMed ID: 8187557
[TBL] [Abstract][Full Text] [Related]
7. [Transitional carcinoma of the bladder. Evaluation of prognostic factors].
Fodor M; Alonso E; Bellotti M; Elsner B; Aparisi I; Pisilli L
Medicina (B Aires); 1993; 53(5):413-8. PubMed ID: 7646600
[TBL] [Abstract][Full Text] [Related]
8. Noninvasive squamous lesions in the urinary bladder: a clinicopathologic analysis of 29 cases.
Guo CC; Fine SW; Epstein JI
Am J Surg Pathol; 2006 Jul; 30(7):883-91. PubMed ID: 16819332
[TBL] [Abstract][Full Text] [Related]
9. Expression of the CD44 cell adhesion molecule in urinary bladder transitional cell carcinoma.
Ross JS; del Rosario AD; Bui HX; Kallakury BV; Okby NT; Figge J
Mod Pathol; 1996 Aug; 9(8):854-60. PubMed ID: 8871928
[TBL] [Abstract][Full Text] [Related]
10. Blood group antigens in epithelial tumours of the urinary bladder.
Marek J; Hradec E; Hanus M; Smolová H
Czech Med; 1988; 11(3):137-45. PubMed ID: 3147171
[TBL] [Abstract][Full Text] [Related]
11. Urothelial (transitional cell) papilloma of the urinary bladder: a clinicopathologic study of 26 cases.
McKenney JK; Amin MB; Young RH
Mod Pathol; 2003 Jul; 16(7):623-9. PubMed ID: 12861056
[TBL] [Abstract][Full Text] [Related]
12. Blood group H antigen in transitional carcinoma of the urinary bladder.
Tichý M; Tichá V; Jansa P; Student V; Vanák J
Acta Univ Palacki Olomuc Fac Med; 1991; 130():157-62. PubMed ID: 1838863
[TBL] [Abstract][Full Text] [Related]
13. Investigation of ABH antigenicity of random mucosal biopsies and transitional cell carcinoma of the urinary bladder.
Jakse G; Hofstädter F
Eur Urol; 1983; 9(2):97-101. PubMed ID: 6852091
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the WHO/ISUP classification and cytokeratin 20 expression in predicting the behavior of low-grade papillary urothelial tumors. World/Health Organization/Internattional Society of Urologic Pathology.
Alsheikh A; Mohamedali Z; Jones E; Masterson J; Gilks CB
Mod Pathol; 2001 Apr; 14(4):267-72. PubMed ID: 11301341
[TBL] [Abstract][Full Text] [Related]
15. [Monoclonal antibodies against transitional cell carcinoma assay tumor associated antigens in different grades bladder cancer patients].
Zhang H; Zhao Z; Sun H
Zhonghua Wai Ke Za Zhi; 1996 Sep; 34(9):560-2. PubMed ID: 9594163
[TBL] [Abstract][Full Text] [Related]
16. [Expression of blood group antigens in 30 patients with transitional-cell carcinomas of the bladder].
Vieillefond A; Quillard J; Meatchi T; Benoit G; Jardin A; Martin E
Ann Pathol; 1987; 7(1):9-14. PubMed ID: 3620025
[TBL] [Abstract][Full Text] [Related]
17. Phenotypically heterogeneous deletion of the ABH antigen from the transformed bladder urothelium. A scanning electron microscope study.
De Harven E; He S; Hanna W; Bootsma G; Connolly JG
J Submicrosc Cytol; 1987 Oct; 19(4):639-49. PubMed ID: 3430650
[TBL] [Abstract][Full Text] [Related]
18. DNA content and proliferation activity in superficial transitional cell carcinoma of the bladder.
Pantazopoulos D; Ioakim-Liossi A; Karakitsos P; Aroni K; Kakoliris S; Kanavaros P; Kyrkou KA
Anticancer Res; 1997; 17(1B):781-6. PubMed ID: 9066620
[TBL] [Abstract][Full Text] [Related]
19. Immunoperoxidase detection of carcinoembryonic antigen and blood group substances in papillary transitional cell carcinoma of the bladder.
Wiley EL; Mendelsohn G; Droller MJ; Eggleston JC
J Urol; 1982 Aug; 128(2):276-80. PubMed ID: 7050419
[TBL] [Abstract][Full Text] [Related]
20. A grading system for the immunostaining of A, B and H blood group isoantigens in bladder carcinoma.
Busch C; Malmström PU; Norlen BJ; Sällström J; Brodin T; Lundblad A
Anticancer Res; 1988; 8(1):81-7. PubMed ID: 3358642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
